000			02108 a2200649 4500
005			20250514013703.0
264		0	_c19910129
008			199101s 0 0 eng d
022			_a0887-378X
040			_aNLM _beng _cNLM
100	1		_aEdgar, Harold
245	0	0	_aNew rules for new drugs: the challenge of AIDS to the regulatory process. _h[electronic resource]
260			_bThe Milbank quarterly _c1990
300			_a111-42 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcquired Immunodeficiency Syndrome _xdrug therapy
650	0	4	_aAttitude to Health
650	0	4	_aClinical Protocols _xstandards
650	0	4	_aClinical Trials as Topic
650	0	4	_aDecision Making
650	0	4	_aDrug Industry _xlegislation & jurisprudence
650	0	4	_aDrugs, Investigational
650	0	4	_aEconomics
650	0	4	_aEthical Review
650	0	4	_aEthics
650	0	4	_aEthics Committees
650	0	4	_aEthics Committees, Research
650	0	4	_aFederal Government
650	0	4	_aGovernment
650	0	4	_aGovernment Regulation
650	0	4	_aHealth Policy _xtrends
650	0	4	_aHistory
650	0	4	_aHuman Experimentation
650	0	4	_aHumans
650	0	4	_aInformed Consent
650	0	4	_aInternational Cooperation
650	0	4	_aInternationality
650	0	4	_aNational Institutes of Health (U.S.)
650	0	4	_aOrganizational Innovation
650	0	4	_aPatient Advocacy
650	0	4	_aPatients
650	0	4	_aPharmaceutical Preparations
650	0	4	_aPhysicians
650	0	4	_aPolitics
650	0	4	_aResearch _xstandards
650	0	4	_aResearch Design
650	0	4	_aResearch Subjects
650	0	4	_aRisk
650	0	4	_aRisk Assessment
650	0	4	_aScientific Misconduct
650	0	4	_aSocial Control, Formal
650	0	4	_aTherapeutic Human Experimentation
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration _xorganization & administration
700	1		_aRothman, David J
773	0		_tThe Milbank quarterly _gvol. 68 _gno. Suppl. 1 _gp. 111-42
999			_c11568698 _d11568698